Drug_ID,Drug,Y
Bis(7)-tacrine (B7T),c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,-5.441246499999999
Terfenadine,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,-5.2600002
fexofenadine,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,-6.5100002
fexofenadine hydrochloride,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl,-5.6999998
2e,C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F,-4.5528421
2j,C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F,-4.5528421
2k,C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F,-4.6382723
49,O=C(N[C@@H]1CCOC[C@@H]1C(=O)NO)c1ccc(Cc2c(C(F)(F)F)nn3ccccc23)cc1,-5.7447276
48,CC(C)(C)c1nn2ccccc2c1Cc1ccc(C(=O)N[C@@H]2CCOC[C@@H]2C(=O)NO)cc1,-5.3665314
6,Cn1c(NCCCN2CCC(CN3c4ccccc4Sc4ccc(C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.8989701
6b,CN(CCCN1CCC(CN2c3ccccc3Sc3ccc(C(=O)O)cc32)CC1)c1cc(=O)n(C)c(=O)n1C,-5.7209244
methylscopolamine,C[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@H]1C1OC12.[Br-],-6.1599998
Setrobuvir (ANA598),CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N/C(=C1\C(=O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2,-5.8899999
Diphenhydramine,CN(C)CCOC(c1ccccc1)c1ccccc1,-4.27
Methadone,CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,-4.6599998
Prednisolone,C[C@]12CC(O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,-5.3699999000000025
677-Prednisolone,C[C@@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,-5.4436975
Methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,-5.1161518
prednisolone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,-4.7199998
Berberrubine (BRB),COc1ccc2cc3[n+](cc2c1O)CCc1cc2c(cc1-3)OCO2,-4.8815303
Umbelliferone,O=c1ccc2ccc(O)cc2o1,-4.5710139000000005
Angelol-A,C/C=C(/C)C(=O)O[C@H](c1cc2ccc(=O)oc2cc1OC)[C@H](O)C(C)(C)O,-4.8123703
Angelol-B,C/C=C(/C)C(=O)O[C@@H]([C@@H](O)c1cc2ccc(=O)oc2cc1OC)C(C)(C)O,-4.8499289
Naringin,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,-6.820000200000001
-,c1ccc(Cc2ccncc2)cc1,-3.9978395
prazosin,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,-4.987
Prazocin,COc1cc2nc(N3CCN(C(=O)c4occc4Cl)CC3)nc(N)c2cc1OC,-4.8899999
omeprazole,COc1ccc2[nH]c(S(=O)Cc3ncc(C)c(OC)c3C)nc2c1,-4.1700001
lansoprazole,Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1,-4.1100001000000015
14c,Cn1c(C(=O)NC2(C(=O)N[C@H](Cc3ccccc3)C(=O)NCCCN3CCOCC3)CCCC2)cc2ccccc21,-4.9723473
Verapamil,COc1ccc(CCN(C)CCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,-4.961279900000001
verapamil,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,-4.579999900000002
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,-5.3899999
Viloxazine,CCOc1ccccc1OCC1CNCCO1,-4.3899999
Byankangelicol,COc1c2ccoc2c(OCC2OC2(C)C)c2oc(=O)ccc12,-4.3000002
EF5248,CCCCOC(=O)COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OCc4oc(=O)oc4C)CC3)CC2=O)cc1,-4.3499999
Ac-C8-Enk-NH (3),CCCCCC[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O,-5.9699998
Met-enkephalin,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O,-7.380000099999997
[D-Ala2]Met-enkephalin,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O,-7.02
Metkephamid,CN[C@@H](CCSC)C(=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1,-7.309999900000001
"877-(2S,4S,5R)-2-[(4'-Chlorophenyl)-4-methyl-1,3-dioxan-5-yl]amine (5h)",C[C@@H]1O[C@@H](c2ccc(Cl)cc2)OC[C@H]1N,-4.9279342
"878-(2S,4S,5R)-2-[(4'-Nitrophenyl)-4-methyl-1,3-dioxan-5-yl]amine (5i)",C[C@@H]1O[C@@H](c2ccc(N(O)O)cc2)OC[C@H]1N,-4.8885694000000015
Celecoxib,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,-4.8050604
60a,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCCN(C)C(=O)[C@@H]4C3)nc(-c3ccccc3)nc2c1C,-4.5900002
67c,COc1ccc2c(O[C@H]3C[C@H]4C(=O)NCCCCC/C=C\[C@@H]5C[C@@]5(C(=O)NS(=O)(=O)C5CC5)NC(=O)[C@@H]4C3)nc(-c3ccc(F)cc3)nc2c1C,-4.4899998
65,CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C,-5.221849
Reserpine,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,-5.3699999000000025
Laudanosine (LAU),COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2C)cc1OC,-4.5497985
XI,CCCCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.5900002
XIV,CCCCCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.77
V,CCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.5500002
VIII,CCCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.5700002
Piroxicam,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,-4.4490995
Exemestane,C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,-4.329999900000002
MEN14268,O=C(NC1(C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCN2CCOCC2)CCCC1)c1cc2ccccc2s1,-5.0478787
ME3229,CCCCOC(=O)COc1ccc(C(=O)CNC(=O)c2cc3c(s2)CCNC3)cc1OCC(=O)OCCCC,-5.1011863
Lobucavir,Nc1nc(O)c2ncn([C@@H]3C[C@H](CO)[C@H]3CO)c2n1,-6.0555172
Rebaudioside A,C=C1C[C@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)OC4O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]4O)C2CC(O[C@H]2O[C@@H](CO)[C@H](O)C(O[C@H]4O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]4O)[C@@H]2O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]1C3,-6.9593034
VLA-4 antagonist 2,CCOC(=O)[C@H](Cc1ccc(OC(=O)N(C)C)cc1)NC(=O)[C@H]1N(S(=O)(=O)c2cnn(C)c2)CSC1(C)C,-5.3699999000000025
VLA-4 antagonist 3,CC(C)OC(=O)[C@H](Cc1ccc(OC(=O)N(C)C)cc1)NC(=O)[C@H]1N(S(=O)(=O)c2cnn(C)c2)CSC1(C)C,-5.170000099999998
VLA-4 antagonist 4,CN(C)C(=O)Oc1ccc(C[C@H](NC(=O)[C@H]2N(S(=O)(=O)c3cnn(C)c3)CSC2(C)C)C(=O)OCC(C)(C)C)cc1,-5.3400002
VLA-4 antagonist 5,CN(C)C(=O)Oc1ccc(C[C@H](NC(=O)[C@H]2N(S(=O)(=O)c3cnn(C)c3)CSC2(C)C)C(=O)OCOC(=O)C(C)(C)C)cc1,-5.5999999
VLA-4 antagonist 6,COCCOCCOC(=O)[C@H](Cc1ccc(OC(=O)N(C)C)cc1)NC(=O)[C@H]1N(S(=O)(=O)c2cnn(C)c2)CSC1(C)C,-5.6900001
Cycloserine,NC1CONC1=O,-5.4400001
3,Cn1c(NCCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)cc(=O)n(C)c1=O,-4.8783755
a-Zearalanol (a-ZAL),CC1CCC(O)CCCCCc2cc(O)cc(O)c2C(=O)OC1,-4.8200002
meloxicam,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,-4.71
propranolol ester,CC(C)NC[C@H](COc1cccc2ccccc12)OC(=O)C1CC1,-4.5100002
Propranolol ester,CC(C)NCC(COc1cccc2ccccc12)OC(=O)C1CC1,-4.1608586
5'-L-phenylalanyl-floxuridine,NC(Cc1ccccc1)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-5.3891382000000005
5'-L-valyl-L-phenylalanyl-floxuridine,CC(C)C(N)C(=O)NC(Cc1ccccc1)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-6.080461
13d,CN1C(=O)CC(N2CCCN(CCCN3c4ccccc4COc4ccc(CC(=O)O)cc43)CC2)N(C)C1=O,-5.8000002
13e,CC(C(=O)O)c1ccc2c(c1)N(CCCN1CCCN(C3CC(=O)N(C)C(=O)N3C)CC1)c1ccccc1CO2,-5.7199998
13g,CN1C(=O)CC(N2CCCN(CCCN3c4ccccc4COc4ccc(C(=O)O)cc43)CC2)N(C)C1=O,-5.5
Tenidap,NC(=O)n1c(O)c(C(=O)c2cccs2)c2cc(Cl)ccc21,-4.3103647
Furazolidone,O=C1OCCN1/N=C/c1ccc(N(O)O)o1,-4.9899998
Xaliproden (SR57746),FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1,-4.73
PNU-184148,O=C(CO)N1CCN(c2ccc(N3C[C@H](CNC(=S)C4CC4)OC3=O)cc2F)CC1,-4.4308991
4c,COC(=O)/C=C/CNC(=O)CN1C(=O)[C@@H](COC(=O)Nc2ccc(Cl)cc2C(F)(F)F)N=C(c2ccccc2)c2ccccc21,-5.4200000999999975
20(S)-camptothecin (CPT),CC[C@]1(O)C(=O)OCc2c1cc1n(c2=O)-c2cc3ccccc3nc2C1,-4.3318486
ganciclovir,Nc1nc(=O)c2ncn(COC(CO)CO)c2[nH]1,-6.3699999000000025
Acyclovir,Nc1nc(=O)c2ncn(COCCO)c2[nH]1,-5.9899998
Diltiazem,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,-4.4043612
SB639,O=C(/C=C/c1ccc2c(c1)nc(CCc1ccccc1)n2CCN1CCCC1)NO,-5.5207167
Cycloastragenol,CC1(C)C2[C@@H](O)C[C@@H]3C4(CC[C@]5(C)[C@@H]([C@]6(C)CC[C@H](C(C)(C)O)O6)[C@@H](O)C[C@@]35C)CC24CC[C@@H]1O,-4.5
fluparoxan,Fc1cccc2c1O[C@H]1CNC[C@@H]1O2,-4.099999899999999
Fluparoxan (GR50360A),Fc1cccc2c1O[C@H]1CNC[C@H]1O2,-3.729485
danazol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,-4.8400002
Danazol,C#C[C@@]1(O)CC[C@@H]2[C@H]3CCC4=Cc5oncc5C[C@@]4(C)[C@@H]3CC[C@]21C,-4.561461
cefazolin,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,-6.23
CD27,CCCCCCCCCC(=O)N1CCNCC1,-3.8199999
